Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-9 ل  9 نتائج ل ""Bone Density Conservation Agents therapeutic use""

فلترة النتائج

Subject : denosumab/therapeutic use
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study.

Subjects: Humans; Female; Middle Aged

  • Source: Bone, vol. 172, pp. 116764

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Updated trabecular bone score accounting for the soft tissue thickness (TBS TT ) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.

Subjects: Female; Humans; Cancellous Bone

  • Source: Osteoporosis international, vol. 33, no. 12, pp. 2517-2525

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus:A Danish Retrospective Cohort Study

Subjects: alendronate; bone; denosumab

  • Source: Viggers , R , Al-Mashhadi , Z , Starup-Linde , J & Vestergaard , P 2022 , ' The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis:A 2-Year Randomized Study

Subjects: ANTIRESORPTIVES; BIOCHEMICAL MARKERS OF BONE TURNOVER; CLINICAL TRIAL

  • Source: Sølling , A S , Harsløf , T & Langdahl , B L 2021 , ' Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis : A 2-Year Randomized Study ' , Journal of

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effets osseux des traitements de bisphosphonates et dénosumab en cas de cancer du sein ou de la prostate

Subjects: info:eu-repo/classification/ddc/616; Androgen Antagonists/therapeutic use; Bone Density

  • Source: ISSN: 1660-9379 ; Revue médicale suisse, vol. 15, no. 647 (2019) p. 824-830.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab:a case report

Subjects: Case report; Denosumab; Melorheostosis

  • Source: Byberg , S , Abrahamsen , B , Kassem , M , Ralston , S & Schwarz , P 2018 , ' Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab : a case report ' ,

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Ostéoporose [Osteoporosis]

Subjects: Aged; Bone Density; Bone Density Conservation Agents/therapeutic use

  • Source: Revue medicale suisse, vol. 18, no. 764-5, pp. 56-58

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.

Subjects: Antibodies; Monoclonal; Humanized/therapeutic use

  • Source: Swiss medical weekly, vol. 147, pp. w14484

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.

Subjects: Bone Density Conservation Agents/therapeutic use; Denosumab/therapeutic use; Diphosphonates/therapeutic use

  • Source: Swiss medical weekly, vol. 146, pp. w14322

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-9 ل  9 نتائج ل ""Bone Density Conservation Agents therapeutic use""